Login Register
English
0

Cart

$ 0

Blocking the LRH-1/LCN2 axis by ML-180, an LRH-1 inverse agonist, ameliorates osteoarthritis via inhibiting the MAPK pathway.(A25112-5.6)

Date:2026-03-03 Views:22